Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| ZIAAI000645 | Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies | 1 | 2025 |
| ZIAAI000646 | Transgenic Animal Models Of Human Immune Defects | 1 | 2025 |
| ZIAAI000732 | Clinical, Immunological and Genetic Analyses of ALPS and Related Immunedysregulatory Disorders | 1 | 2025 |
| ZIAAI000989 | Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies | 1 | 2025 |
| ZIAAI001059 | Defining New Human Immunodeficiency and Immunodysregulation Disorders | 1 | 2025 |
| ZIAAI001083 | Studies in the Pathogenesis of Systemic Capillary Leak Syndrome | 1 | 2025 |
| ZIAAI001092 | Pathogenesis and Treatment of Anaphylaxis | 1 | 2025 |
| ZIAAI001121 | Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease | 1 | 2025 |
| ZIAAI001130 | Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease | 1 | 2025 |
| ZIAAI001175 | Immunopathogenesis of Fungal Infections | 1 | 2025 |
| ZIAAI001203 | The Role of Transforming Growth Factor Beta (TGFbeta) in Promoting Allergic Inflammation | 1 | 2025 |
| ZIAAI001220 | Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases | 1 | 2025 |
| ZIAAI001222 | Characterization of the cellular and molecular bases of inborn errors of immunity | 1 | 2025 |
| ZIAAI001242 | Comprehensive multimodal analysis of patients with neuroimmunological diseases | 1 | 2025 |
| ZIAAI001310 | Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseases | 1 | 2025 |
| ZIAAR041213 | Integrative genomic analysis of the human response to glucocorticoids | 1 | 2025 |
| ZIABC006150 | DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs | 1 | 2025 |
| ZIABC010440 | Protein Structure, Stability, and Amyloid Formation | 1 | 2025 |
| ZIABC011002 | Bioinformatics, Machine Learning, Systems Biology of Cancers | 1 | 2025 |
| ZIABC011746 | Development Therapeutics Branch Clinical Trials | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=19